The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

about

Potential Involvement of the Epidermal Growth Factor Receptor Ligand Epiregulin and Matrix Metalloproteinase-1 in Pathogenesis of Chronic Rhinosinusitis.

P2860

Q47923013-5195FEB9-D498-4E0C-AEFA-EB8B4D1025A2

P2860

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

Item

http://www.wikidata.org/entity/Q48083642

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

@en

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

@nl

type

Item

label

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

@en

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

@nl

prefLabel

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

@en

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

@nl

P1476

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps

@en

P2093

Barbara Wollenberg

http://www.w3.org/2001/XMLSchema#string

Karl-Ludwig Bruchhage

http://www.w3.org/2001/XMLSchema#string

Maximilian Gebhard

http://www.w3.org/2001/XMLSchema#string

Ralph Pries

http://www.w3.org/2001/XMLSchema#string

Robert Böscke

http://www.w3.org/2001/XMLSchema#string

Robert Linke

http://www.w3.org/2001/XMLSchema#string

P2860

ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF

PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif.

Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase.

Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Chronic rhinosinusitis and asthma: novel understanding of the role of IgE 'above atopy'

Cystic fibrosis

The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product

The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2

MAP kinase signalling pathways in cancer

P2888

s00005-014-0281-2

P304

217-229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00005-014-0281-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Könnecke

P577

2014-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24609540

http://www.w3.org/2001/XMLSchema#string

P921

rhinosinusitis

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

about

P2860

P2860

The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921